Dhiver C - Search Results

1

Reevaluation of possible outcomes of infections with human immunodeficiency virus.

Tamalet C, Colson P, Decroly E, Dhiver C, Ravaux I, Stein A, Raoult D. Tamalet C, et al. Among authors: dhiver c. Clin Microbiol Infect. 2016 Apr;22(4):299-311. doi: 10.1016/j.cmi.2015.11.022. Epub 2016 Jan 18. Clin Microbiol Infect. 2016. PMID: 26794031 Free article. Review.

2

[Serological prevalence of hepatitis C virus in a population infected with HIV].

Lafeuillade A, Zandotti C, Tamalet C, Poizot-Martin I, Dhiver C, Quilichini R, Gastaut JA. Lafeuillade A, et al. Among authors: dhiver c. Presse Med. 1990 Nov 10;19(37):1725. Presse Med. 1990. PMID: 2147496 French. No abstract available.

3

Pilot phase I study using zidovudine in association with a 10-day course of anti-CD4 monoclonal antibody in seven AIDS patients.

Dhiver C, Olive D, Rousseau S, Tamalet C, Lopez M, Galindo JR, Mourens M, Hirn M, Gastaut JA, Mawas C. Dhiver C, et al. AIDS. 1989 Dec;3(12):835-42. doi: 10.1097/00002030-198912000-00009. AIDS. 1989. PMID: 2576628

4

Autologous neutralizing antibodies and viral load in HIV-2-infected individuals.

Tamalet C, Simon F, Dhiver C, Matheron S, de Micco P, Gastao JA, Brun-Vézinet F. Tamalet C, et al. Among authors: dhiver c. AIDS. 1995 Jan;9(1):90-1. AIDS. 1995. PMID: 7893447 No abstract available.

5

Cellular and plasma viral load in patients infected with HIV-2.

Simon F, Matheron S, Tamalet C, Loussert-Ajaka I, Bartczak S, Pépin JM, Dhiver C, Gamba E, Elbim C, Gastaut JA, et al. Simon F, et al. Among authors: dhiver c. AIDS. 1993 Nov;7(11):1411-7. doi: 10.1097/00002030-199311000-00002. AIDS. 1993. PMID: 7904166

6

Absent inhibition of hepatitis B virus replication by azidothymidine in patients chronically coinfected by HIV-1 and HBV.

Gallian P, De Lamballerie X, Lehucher MP, Dhiver C, Ravaux I. Gallian P, et al. Among authors: dhiver c. New Microbiol. 1996 Apr;19(2):167-9. New Microbiol. 1996. PMID: 8722313

7

Multidrug resistance genotypes (insertions in the beta3-beta4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: incidence and association with other resistance mutations.

Tamalet C, Yahi N, Tourrès C, Colson P, Quinson AM, Poizot-Martin I, Dhiver C, Fantini J. Tamalet C, et al. Among authors: dhiver c. Virology. 2000 May 10;270(2):310-6. doi: 10.1006/viro.2000.0261. Virology. 2000. PMID: 10792990 Free article.

8

Evolution of HIV-1 multidrug-resistant genotypes during combination therapy and after the cessation of antiretroviral drugs.

Yahi N, Tourrès C, Tivoli N, Colson P, Dhiver C, Quinson AM, Tamalet C. Yahi N, et al. Among authors: dhiver c. AIDS. 2000 Dec 22;14(18):2943-5. doi: 10.1097/00002030-200012220-00019. AIDS. 2000. PMID: 11153678 No abstract available.

9

TT virus infection: prevalence of elevated viraemia and arguments for the immune control of viral load.

Touinssi M, Gallian P, Biagini P, Attoui H, Vialettes B, Berland Y, Tamalet C, Dhiver C, Ravaux I, De Micco P, De Lamballerie X. Touinssi M, et al. Among authors: dhiver c. J Clin Virol. 2001 May;21(2):135-41. doi: 10.1016/s1386-6532(01)00157-3. J Clin Virol. 2001. PMID: 11378494

10

Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a non-nucleoside reverse transcriptase inhibitor.

Solas C, Poizot-Martin I, Drogoul MP, Ravaux I, Dhiver C, Lafeuillade A, Allegre T, Mokhtari M, Moreau J, Lepeu G, Petit N, Durand A, Lacarelle B. Solas C, et al. Among authors: dhiver c. Br J Clin Pharmacol. 2004 Apr;57(4):436-40. doi: 10.1046/j.1365-2125.2003.02020.x. Br J Clin Pharmacol. 2004. PMID: 15025741 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters